GPT and metabolic syndrome: Most patients 13/25 (52%) were classified with moderate ataxia, 16/25 (64%) had dyslipidemia, 4/23 (17%) were diabetic (three diagnosed by OGTT performed in this study), 5/21 (23.8%) had IR according to HOMA-AD and 5/25 (20%) had values equal to or greater than twice the upper limit of normal for AST and ALT enzymes.